Why IART fell 20.6% on Oct 2 2026: flooding guidance cut
IART-20.6%on Fri Oct 2 2026
Integra LifeSciences Holdings was down 20.6% on the day at $12.77, ranked #4 on 51.4× its usual five-minute volume, when TapeRank recorded this drop at 11:32 ET during regular hours.
THE DAY ON THE LIST · 1 EVENT
- 11:32 ETMOVER · REGULAR
$12.77 · ▼ 20.6% ON THE DAY · 51.4× 5M RVOL · RANK #4
JUSTIFIEDCONFIDENCE5/5IART is down 20.6% after flooding-related supply disruptions cut expected revenue and reduced full-year adjusted EPS guidance by $0.10. The prolonged Cincinnati facility outage, including an estimated $15 million-$20 million fourth-quarter revenue hit and recovery only in Q2 2027, is material enough to explain the sharp decline.
WHYA 20.6% drop is large, but it is broadly proportionate to a multi-quarter operational disruption, reduced guidance, and delayed manufacturing recovery.ANALYZED 11:48 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 11:32 ET
LAST12.77DAY▼ 20.6%5 MIN▼ 1.92%5M RVOL51.4×5M $VOL$1.6MFLOAT*77.8MRANK#4SESSIONREGULARVWAP13.48HOD16.13LOD12.90OR HIGH14.00OR LOW13.28PREV CLOSE16.09PM HIGH16.13PM LOW13.11GAP▼ 17.28%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $13.31, -17.3% on the previous close of $16.09
- 09:32 ETRegular-session high, $14.00
- 12:08 ETRegular-session low, $12.63
- 15:59 ETLast trade of the regular session, $12.69, -21.2% on the previous close of $16.09
- Volume: 2.5M shares in regular hours, 17K before the open
IART opened at $13.31, well below the previous close of $16.09, briefly reached $14.00, then fell to a $12.63 low by 12:08 ET. TapeRank recorded the stock at $12.77 and read the move as justified by flooding-related supply disruptions, which were expected to cut revenue, reduce full-year adjusted EPS guidance by $0.10, and delay recovery at the Cincinnati facility until Q2 2027. With no halts, the stock ended the regular session at $12.69, down 21.2% from the previous close.
WRITTEN THU OCT 15 2026 18:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 08:20 ET8-K — Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and ExhibitsSEC 8-K
- 08:09 ETIntegra LifeSciences Anticipates Flooding Related Supply Disruption To Impact Q3 Revenue By ~$7M, Q4 Revenue By $15M - $20M; Expects Q3 Revenue Range Of ~$410M - $412M, Adjusted EPS Range $0.55 - $0.59; Updates FY26 Adjusted EPS Range From $2.40 - $2.50 To $2.30 - $2.40, Revenue Range From $1.654B - $1.695B To $1.634B - $1.654BBenzinga
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list